J Pharm Pharm Sci. 2013;16(5):722-31. doi: 10.18433/j3nc8p.
Intestinal ischemia-reperfusion (I/R) causes gut dysfunction and promotes multi-organ failure. The liver and kidney can be affected by multi-organ failure after intestinal I/R. Organic anion transporting polypeptides (OATPs) and organic anion transporters (OATs) are recognized in a broad spectrum from endogenous compounds to xenobiotics, including clinically important drugs. Therefore, it is important for understanding the pharmacokinetics to obtain evidence of alterations in OATPs and OATs expression and transport activities. In the present study, we investigated the expression of rat Oatps and Oats after intestinal I/R.
We used intestinal ischemia-reperfusion (I/R) model rats. Real-time PCR and Western blotting were used to assess mRNA and protein expression levels. Plasma concentration and biliary excretion of sulfobromophthalein (BSP), which is used as a model compound of organic anion drugs, were measured after intravenous administration in intestinal I/R rats.
Although Oat1 and Oat3 mRNA levels were not altered in the kidney, Oatp1a1, Oatp1b2 and Oatp2b1 mRNA levels in the liver were significantly decreased at 1-6 h after intestinal I/R. Moreover, Oatp1a1 and Oatp2b1 protein expression levels were decreased at 1 h after intestinal I/R. Plasma concentration of BSP, which is a typical substrate of Oatps, in intestinal I/R rats reperfused 1 h was increased than that in sham-operated rats. Moreover, the area under the concentration-time curve (AUC₀₋₉₀) in intestinal I/R rats reperfused 1 h was significantly increased than that in sham-operated rats. The total clearance (CL(tot)) and the biliary clearance (CL(bile)) in intestinal I/R rats reperfused 1 h were significantly decreased than those in sham-operated rats.
Oatp1a1 and Oatp2b1 expression levels are decreased by intestinal I/R. The decreases in these transporters cause alteration of pharmacokinetics of organic anion compound. The newly found influence of intestinal I/R on the expression and function of Oatps may be a key to perform appropriate drug therapy.
肠缺血再灌注(I/R)可导致肠道功能障碍并促进多器官衰竭。肝脏和肾脏会受到肠 I/R 后多器官衰竭的影响。有机阴离子转运多肽(OATPs)和有机阴离子转运体(OATs)广泛识别内源性化合物和外源性化合物,包括临床上重要的药物。因此,了解 OATPs 和 OATs 表达和转运活性的变化对于获得药代动力学证据非常重要。在本研究中,我们研究了肠 I/R 后大鼠 Oatps 和 Oats 的表达情况。
我们使用肠缺血再灌注(I/R)模型大鼠。实时 PCR 和 Western blot 用于评估 mRNA 和蛋白表达水平。在肠 I/R 大鼠中静脉给药后,测量磺溴酞(BSP)的血浆浓度和胆汁排泄,BSP 用作有机阴离子药物的模型化合物。
尽管肾脏中 Oat1 和 Oat3 mRNA 水平没有改变,但肠 I/R 后 1-6 小时肝脏中 Oatp1a1、Oatp1b2 和 Oatp2b1 mRNA 水平显著降低。此外,肠 I/R 后 1 小时 Oatp1a1 和 Oatp2b1 蛋白表达水平降低。肠 I/R 再灌注 1 小时大鼠的 BSP 血浆浓度(Oatps 的典型底物)高于假手术大鼠。此外,肠 I/R 再灌注 1 小时大鼠的 AUC₀₋₉₀显著高于假手术大鼠。肠 I/R 再灌注 1 小时大鼠的总清除率(CL(tot))和胆汁清除率(CL(bile))明显低于假手术大鼠。
肠 I/R 降低了 Oatp1a1 和 Oatp2b1 的表达水平。这些转运体的减少导致了有机阴离子化合物药代动力学的改变。肠 I/R 对 Oatps 表达和功能的新发现影响可能是进行适当药物治疗的关键。